Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Genetics Expert Talks about Trends in Newborn Screening and the Orphan Drug Act

February 05, 2015

As part of an editorial collaboration with Medscape Rare Diseases, Marshall Summar, MD, Chief of the Division of Genetics and Metabolism, interviewed Jess Thoene, one of the founders and pioneers in the field of inborn errors in metabolism in rare diseases about newborn screening and the impact of the Orphan Drug Act.

Read the full article here.

Latest Tweets

Follow